"ファイザー" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonPfizer, Novo again raise Metsera bids in intensifying obesity drug battle - Reuters
Pfizer Earnings: In-Line Quarter Despite Covid Product Weakness as Metsera Drama Intensifies - Mo...
Pfizer Earnings: In-Line Quarter Despite Covid Product Weakness as Metsera Drama Intensifies Morningstar
Pfizer tops estimates, raises profit guidance even as sales fall - CNBC
Pfizer tops estimates, raises profit guidance even as sales fall CNBC
Jim Cramer Says Pfizer “Will Continue to Sell at Eight Times Earnings” - Yahoo Finance
Jim Cramer Says Pfizer “Will Continue to Sell at Eight Times Earnings” Yahoo Finance
Pfizer moves into the VEGF bispecific fast lane | ApexOnco - Clinical Trials news and analysis - ...
Pfizer moves into the VEGF bispecific fast lane | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Pfizer’s Slow Burn Comeback (NYSE:PFE) - Seeking Alpha
Pfizer’s Slow Burn Comeback (NYSE:PFE) Seeking Alpha
Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows - AP News
Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows AP News
Pfizer's Prevnar, Abrysvo and Comirnaty suffer Q3 sales declines amid tough US market for vaccine...
Pfizer's Prevnar, Abrysvo and Comirnaty suffer Q3 sales declines amid tough US market for vaccines Fierce Pharma
Pfizer COVID-19 vaccine sales drop 25% after confusing government guidance on the shot - the-inde...
Pfizer COVID-19 vaccine sales drop 25% after confusing government guidance on the shot the-independent.com
Pfizer Responds to Delaware Chancery Court Ruling - Business Wire
Pfizer Responds to Delaware Chancery Court Ruling Business Wire
Metsera Wins Legal Battle Against Pfizer - TipRanks
'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera - Investor...
'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera Investor's Business Daily
There is only one winner in the Pfizer Novo Nordisk showdown - Financial Times
There is only one winner in the Pfizer Novo Nordisk showdown Financial Times
Exclusive | Pfizer Preps Improved Offer in Metsera Bidding War - WSJ - The Wall Street Journal
Exclusive | Pfizer Preps Improved Offer in Metsera Bidding War - WSJ The Wall Street Journal
Melodrama at the FDA and the Pfizer-Novo bidding war - statnews.com
Melodrama at the FDA and the Pfizer-Novo bidding war statnews.com
Pfizer Profit Falls Amid Lower Covid-19 Drug Demand - WSJ - The Wall Street Journal
Pfizer Profit Falls Amid Lower Covid-19 Drug Demand - WSJ The Wall Street Journal
Pfizer: The Storm Has Passed — Tailwinds Ahead (NYSE:PFE) - Seeking Alpha
Pfizer: The Storm Has Passed — Tailwinds Ahead (NYSE:PFE) Seeking Alpha
Novo’s Metsera Bid Attracts FTC Scrutiny as Pfizer Matches $10B Offer - BioSpace
Novo’s Metsera Bid Attracts FTC Scrutiny as Pfizer Matches $10B Offer BioSpace
Novo Nordisk CEO Challenges Pfizer to Raise its Bid for Metsera - Bloomberg.com
Novo Nordisk CEO Challenges Pfizer to Raise its Bid for Metsera Bloomberg.com
Novo Nordisk challenges Pfizer to raise offer for obesity biotech - Financial Times
Novo Nordisk challenges Pfizer to raise offer for obesity biotech Financial Times
Why Pfizer and Novo are duking it out over weight loss startup Metsera - PharmaVoice
Why Pfizer and Novo are duking it out over weight loss startup Metsera PharmaVoice
What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war? - Reuters
What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war? Reuters
Jim Cramer Highlights the Woes of Pfizer and the Drug Sector - Yahoo Finance
Jim Cramer Highlights the Woes of Pfizer and the Drug Sector Yahoo Finance
Bidding war between Pfizer, Novo Nordisk for obesity startup Metsera escalates - statnews.com
Bidding war between Pfizer, Novo Nordisk for obesity startup Metsera escalates statnews.com
Pfizer Loses Legal Bid to Temporarily Block Novo’s Metsera Offer - Bloomberg.com
Pfizer Loses Legal Bid to Temporarily Block Novo’s Metsera Offer Bloomberg.com
Delaware Court Denies Pfizer’s Bid To Block Novo-Metsera Deal - BioSpace
Delaware Court Denies Pfizer’s Bid To Block Novo-Metsera Deal BioSpace
Pfizer plans on sweetening offer for obesity drugmaker Metsera, source says - Reuters
Pfizer plans on sweetening offer for obesity drugmaker Metsera, source says Reuters
Pfizer’s view on the Metsera bidding war - statnews.com
Pfizer’s view on the Metsera bidding war statnews.com
Pfizer files second lawsuit against Novo Nordisk, Metsera in battle over obesity startup - statne...
Pfizer files second lawsuit against Novo Nordisk, Metsera in battle over obesity startup statnews.com
Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera - Reuters
Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera Reuters
Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit - Reuters
Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit Reuters
Pfizer preparing to raise its bid for Metsera, WSJ reports - Reuters
Pfizer preparing to raise its bid for Metsera, WSJ reports Reuters
Metsera again chooses Novo as bidding war with Pfizer intensifies - BioPharma Dive
Metsera again chooses Novo as bidding war with Pfizer intensifies BioPharma Dive
Delaware judge says she will not block Metsera from ending Pfizer deal - Reuters
Delaware judge says she will not block Metsera from ending Pfizer deal Reuters
Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight - Reuters
Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight Reuters
Updated: Novo Nordisk raises Metsera bid again, hoping to top Pfizer's latest offer - Endpoints News
Updated: Novo Nordisk raises Metsera bid again, hoping to top Pfizer's latest offer Endpoints News
Novo again ups the stakes after Pfizer reportedly matches $10B bid for Metsera - FirstWord Pharma
Novo again ups the stakes after Pfizer reportedly matches $10B bid for Metsera FirstWord Pharma
Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup Metsera - WSJ - The Wall S...
Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup Metsera - WSJ The Wall Street Journal
Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo...
Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo Reuters
Pfizer matching Novo Nordisk's $10B bid for obesity drug maker Metsera after legal setback - The ...
Pfizer matching Novo Nordisk's $10B bid for obesity drug maker Metsera after legal setback The Business Journals
Pfizer Fields Novo’s $10B Curveball, With Bourla Promising To Fight for Metsera - BioSpace
Pfizer Fields Novo’s $10B Curveball, With Bourla Promising To Fight for Metsera BioSpace
Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting - Yahoo Finance
Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting Yahoo Finance
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up - Reuters
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up Reuters
Pfizer Hikes Earnings Outlook Even As Third-Quarter Sales Decline - Investor's Business Daily
Pfizer Hikes Earnings Outlook Even As Third-Quarter Sales Decline Investor's Business Daily
Pfizer and Novo fatten their bids for weight-loss drugmaker Metsera - Axios
Pfizer and Novo fatten their bids for weight-loss drugmaker Metsera Axios
Novo and Pfizer make their America First case in their fight over an anti-obesity biotech - Axios
Novo and Pfizer make their America First case in their fight over an anti-obesity biotech Axios
Pfizer Boosts Profit View While Chasing Obesity Startup Metsera - Bloomberg.com
Pfizer Boosts Profit View While Chasing Obesity Startup Metsera Bloomberg.com
Pfizer's parade of pipeline cuts: Seagen, BioNTech and MASH programs among 11 axed - Fierce Biotech
Pfizer's parade of pipeline cuts: Seagen, BioNTech and MASH programs among 11 axed Fierce Biotech
Novo, Pfizer's bidding war heats up with supercharged offers for Metsera - Fierce Biotech
Novo, Pfizer's bidding war heats up with supercharged offers for Metsera Fierce Biotech
Pfizer Stock Falls on Third-Quarter Earnings. What Covid-19 Has to Do With It. - Barron's
Pfizer Stock Falls on Third-Quarter Earnings. What Covid-19 Has to Do With It. Barron's
Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk - WSJ - The Wall Street Journal
Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk - WSJ The Wall Street Journal
Henlius goes on the anti-Pfizer offensive | ApexOnco - Clinical Trials news and analysis - Oncolo...
Henlius goes on the anti-Pfizer offensive | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Pfizer matches Novo bid for obesity biotech Metsera as takeover battle rages - FT (PFE:NYSE) - Se...
Pfizer matches Novo bid for obesity biotech Metsera as takeover battle rages - FT (PFE:NYSE) Seeking Alpha
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech - CNBC
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech CNBC
Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga - Bloomberg.com
Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga Bloomberg.com
Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal - Benzinga
Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal Benzinga
Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting - The Motley Fool
Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting The Motley Fool
Pfizer matches Novo bid for obesity biotech Metsera as takeover battle rages - Financial Times
Pfizer matches Novo bid for obesity biotech Metsera as takeover battle rages Financial Times
Pfizer Matches Novo's $10B Metsera Bid, And Other Rumors - Law360
Pfizer Matches Novo's $10B Metsera Bid, And Other Rumors Law360
Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revi...
Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo - Investor's Business Daily
Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo Investor's Business Daily
Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera - Barron's
Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera Barron's
Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting - Nasdaq
Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting Nasdaq
Novo Nordisk CEO 'feels' Danish pharma will bag Metsera at end of Pfizer bidding war - Fierce Bio...
Novo Nordisk CEO 'feels' Danish pharma will bag Metsera at end of Pfizer bidding war Fierce Biotech
Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera - Barron's
Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera Barron's
Jim Cramer Says Pfizer “Will Continue to Sell at Eight Times Earnings” - Insider Monkey
Jim Cramer Says Pfizer “Will Continue to Sell at Eight Times Earnings” Insider Monkey
Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid - Financial Times
Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid Financial Times
Pfizer reports earnings beat and boosts guidance as Metsera bid-off heats up - Sherwood News
Pfizer reports earnings beat and boosts guidance as Metsera bid-off heats up Sherwood News
Novo Nordisk and Pfizer sweeten offers for Metsera as bidding war intensifies - Financial Times
Novo Nordisk and Pfizer sweeten offers for Metsera as bidding war intensifies Financial Times
Pfizer Inc (PFE) Q3 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... ...
Pfizer Inc (PFE) Q3 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... Yahoo Finance
How Pfizer's (PFE) Metsera Legal Fight and Q3 Dip Could Reshape Its Innovation Strategy - Yahoo F...
How Pfizer's (PFE) Metsera Legal Fight and Q3 Dip Could Reshape Its Innovation Strategy Yahoo Finance
Pfizer (PFE): Is There Untapped Value in Today’s Evolving Pharmaceutical Market? - Yahoo Finance
Pfizer (PFE): Is There Untapped Value in Today’s Evolving Pharmaceutical Market? Yahoo Finance
Pfizer plays hardball in weight-loss drug fight - Financial Times
Pfizer plays hardball in weight-loss drug fight Financial Times
Pfizer files second lawsuit against Metsera, Novo Nordisk - Yahoo Finance
Pfizer files second lawsuit against Metsera, Novo Nordisk Yahoo Finance
Metsera gets higher bids from Novo Nordisk, Pfizer in bidding war (MTSR:NASDAQ) - Seeking Alpha
Metsera gets higher bids from Novo Nordisk, Pfizer in bidding war (MTSR:NASDAQ) Seeking Alpha
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockhol...
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk Yahoo Finance
Pfizer: Market Still Pricing It At Crisis Valuations (PFE) - Seeking Alpha
Pfizer: Market Still Pricing It At Crisis Valuations (PFE) Seeking Alpha
Novo CEO, in bidding war with Pfizer, says Metsera’s drugs would complement pipeline - statnews.com
Novo CEO, in bidding war with Pfizer, says Metsera’s drugs would complement pipeline statnews.com
Pfizer Lawsuits Allege Novo Nordisk’s Bid to Buy Obesity Biotech Metsera is Anticompetitive, Ille...
Pfizer Lawsuits Allege Novo Nordisk’s Bid to Buy Obesity Biotech Metsera is Anticompetitive, Illegal MedCity News
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance - Business ...
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance Business Wire
AMD, Uber, Pfizer earnings on deck; ADP job data: What to Watch - Yahoo Finance
AMD, Uber, Pfizer earnings on deck; ADP job data: What to Watch Yahoo Finance
Pfizer slams Delaware court ruling on Novo bid for Metsera - The Pharma Letter
Pfizer slams Delaware court ruling on Novo bid for Metsera The Pharma Letter
Pfizer’s (NYSE:PFE) Q3 Earnings Results: Revenue In Line With Expectations - Yahoo Finance
Pfizer’s (NYSE:PFE) Q3 Earnings Results: Revenue In Line With Expectations Yahoo Finance
Pfizer's Q3: Stagnation Continues (NYSE:PFE) - Seeking Alpha
Pfizer's Q3: Stagnation Continues (NYSE:PFE) Seeking Alpha
Pfizer's $4.9 Billion Gamble: Inside Its Legal War to Reclaim the Obesity Market - Yahoo Finance
Pfizer's $4.9 Billion Gamble: Inside Its Legal War to Reclaim the Obesity Market Yahoo Finance
Novo Ups Ante In Metsera Buyout Drama With $10B Offer, Beating Pfizer’s New Bid - BioSpace
Novo Ups Ante In Metsera Buyout Drama With $10B Offer, Beating Pfizer’s New Bid BioSpace
Novo Nordisk and Pfizer’s bidding war for Metsera escalates despite legal threats - Pharmaceutica...
Novo Nordisk and Pfizer’s bidding war for Metsera escalates despite legal threats Pharmaceutical Technology
Pfizer Loses Legal Bid to Temporarily Block Novo’s Metsera Offer - Crain's New York Business
Pfizer Loses Legal Bid to Temporarily Block Novo’s Metsera Offer Crain's New York Business
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance - Yahoo Fin...
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance Yahoo Finance
Delaware judge says she will not block Metsera from ending Pfizer deal - Yahoo! Finance Canada
Delaware judge says she will not block Metsera from ending Pfizer deal Yahoo! Finance Canada
Weight-loss wars: $10bn hostile battle pits Pfizer against Novo Nordisk - Financial Times
Weight-loss wars: $10bn hostile battle pits Pfizer against Novo Nordisk Financial Times
Pfizer raises earnings outlook as COVID vaccine sales drive Q3 beat - Seeking Alpha
Pfizer raises earnings outlook as COVID vaccine sales drive Q3 beat Seeking Alpha
3 Forces That Could Shake Pfizer Stock - Trefis
Jim Cramer Highlights the Woes of Pfizer and the Drug Sector - Insider Monkey
Jim Cramer Highlights the Woes of Pfizer and the Drug Sector Insider Monkey
Pfizer is losing its fight with Novo Nordisk to get back in the obesity-drug game - MarketWatch
Pfizer is losing its fight with Novo Nordisk to get back in the obesity-drug game MarketWatch
Novo Nordisk downgrades sales outlook again amid bidding war with Pfizer for Metsera - MarketWatch
Novo Nordisk downgrades sales outlook again amid bidding war with Pfizer for Metsera MarketWatch
Pfizer loses bid to temporarily block Novo Nordisk's Metsera offer (MTSR:NASDAQ) - Seeking Alpha
Pfizer loses bid to temporarily block Novo Nordisk's Metsera offer (MTSR:NASDAQ) Seeking Alpha
Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle By Reuters - Inves...
Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle By Reuters Investing.com
Delaware judge refuses to block Metsera from ending Pfizer obesity deal - Endpoints News
Delaware judge refuses to block Metsera from ending Pfizer obesity deal Endpoints News
Delaware court won't rule on Pfizer/Novo battle for Metsera today - Seeking Alpha
Delaware court won't rule on Pfizer/Novo battle for Metsera today Seeking Alpha